Capital Markets

About

Provided by Herbst Kinsky Rechtsanwälte GmbH

WHAT HERBST KINSKY IS BEST KNOWN FOR:

IPO´s (eg Marinomed Biotech AG)

Public Listing as Biogena in 2020

Specialist in structuring and setting up alternative and/or private equity funds

Debt know-how in crowd investing

Public offerings through crowd investing platforms (BIOGENA, NEOH, dagobertinvest)

Public Take-overs

Preparation of Prospectus

EU and US Sanction Law

SPOs and private placements of public listed companies

Specialist in alternative financial offerings

Employee Stock Option Programs for public listed companies

Advising of listed companies on various capital market law aspects (ams AG: EUR 4,3 billion on the acquisition of OSRAM Licht AG)

regulatory work

Compliance matters (in particular KYC – EMR)

FINTECH/Crypto Assets/NFT

SPECIALIST WITH FORESIGHT

We are proven experts in Austrian capital market law and represent both issuers and issuing banks in national and international issues of shares and bonds. In addition to drawing up tender and bid documentation we are particularly specialised in negotiating mandate and takeover agreements, comfort letters as well as advice in the fields of corporate governance and compliance.